💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
User | Tweets |
---|---|
@TradingSin21 | 18 |
@nekeji2097 | 11 |
@newsfilterio | 8 |
@bthefirsttoknow | 7 |
@FlashAlert_me | 7 |
![]() |
@PeterHa18329727 $BIIB *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/v9tCYcZ0nW 4:01am |
![]() |
@WhortonKathleen $BIIB "ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED.??..?~~ https://t.co/Z2GnoT8lsq 2:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 4: Insider ALEXANDER SUSAN H: Granted 5,703 of Common Stock at price $0 on 202… https://t.co/q3VC2TWyNa 2:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 5: Insider Posner Brian S: Gifted 150 of Common Stock at price $0 on 2022-06-0… https://t.co/ASlCAAYrKT 2:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 4: Insider Kramer Robin: Granted 887 of Common Stock at price $0 on 2023-01-25… https://t.co/CqVKqpkVTO 2:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 4: Insider Singhal Priya: Granted 1,123 of Common Stock at price $0 on 2023-01… https://t.co/tz3Bizz6EZ 1:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 4: Insider Murphy Nicole: Granted 1,340 of Common Stock at price $0 on 2023-01… https://t.co/Hv5DW88nGd 1:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 5: Insider SHERWIN STEPHEN A: Gifted 695 of Common Stock at price $0 on 2022-1… https://t.co/bojRwnAejt 1:01am |
![]() |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 4: Insider Gregory Ginger: Granted 4,452 of Common Stock at price $0 on 2023-0… https://t.co/CPDErdodOK 1:01am |
![]() |
@BBaccSoon @tradezero charging almost five a night to short literally two shares of $BIIB even though their own software shows… https://t.co/DoY0skLHTt 12:01am |
![]() |
@Bulgari24287297 $BIIB Top analyst price target for next week....~ ?https://t.co/xQRlbf04l2 12:01am |
![]() |
@Slayer10Stock $BIIB Put-Call ratio by Volume => 0.49 @ 2023-01-27. Learn more at https://t.co/54bj3mKa5j. #BIIBSTOCK #Ticker https://t.co/ht3WHl8fVJ January 27th 2023, 11:01pm |
![]() |
@newsfilterio Form 5 (annual statement of changes in beneficial ownership of securities) filed with the SEC $BIIB https://t.co/1XC13dWyyg January 27th 2023, 11:01pm |
![]() |
@newsfilterio Form 5 (annual statement of changes in beneficial ownership of securities) filed with the SEC $BIIB https://t.co/c8QMcvrVfv January 27th 2023, 11:01pm |
![]() |
@TradingSin21 $BIIB Trading Ideas | Awaiting Short signal. 100% Profitability based on 3 trades. Profit factor is 100. Learn more… https://t.co/7pr8eoaQTY January 27th 2023, 8:01pm |
![]() |
@jbetlach (Reuters) - Japanese drugmaker Eisai Co Ltd and Biogen Inc $BIIB said on Thursday the European Medicines Agency (EM… https://t.co/YWsLYP5Tuh January 27th 2023, 4:01pm |
![]() |
@TroyAda06584292 $BIIB *Top analyst target price for next week - https://t.co/JqhJc6wi6Q January 27th 2023, 3:01pm |
![]() |
@PopplewellTy RT @ParagonIntelNYC: Today at 1pm ET we are hosting a call on our work on $BIIB CEO Viehbacher We are Positive on CEO Viehbacher strategic… January 27th 2023, 1:01pm |
![]() |
@prosan40618812 $BIIB "ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED>?? https://t.co/lhVgPnAEZJ January 27th 2023, 1:01pm |
![]() |
@Any57746051 $BIIB Top analyst price target for next week??>? ?https://t.co/KtniMl2W5C January 27th 2023, 12:01pm |
![]() |
@ConnorJBates_ $BIIB Potentially getting ready for a big move soon. 3 consecutive days of very tight price action and volume contr… https://t.co/lMYMcukdxO January 27th 2023, 12:01pm |
![]() |
@ParagonIntelNYC Today at 1pm ET we are hosting a call on our work on $BIIB CEO Viehbacher We are Positive on CEO Viehbacher strate… https://t.co/OhKaEeFyXX January 27th 2023, 12:01pm |
![]() |
@Gambiste1 RT @semodough: Goldberg - correct also as uptake of $BIIB Leqembi for Alzheimer’s Disease will likely ramp up in ‘24/’25” Bodes very Positi… January 27th 2023, 4:01am |
![]() |
@LauermanJohn RT @ZacharyBrennan: Europe wants in on lecanemab (Aduhelm was rejected there) $biib https://t.co/r85hcivrTp January 27th 2023, 4:01am |
![]() |
@steintrades RT @MichaelWalstedt: $BIIB textbook @markminervini VCP setup here Super tight price action with the largest decline coming in at only -15%… January 27th 2023, 3:01am |
![]() |
@bthefirsttoknow First out// $BIIB: European Medicines Agency Accepted Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer's January 27th 2023, 12:01am |
![]() |
@Ainvest_Wire EU regulator accepts for review Alzheimer's treatment from Eisai-Biogen - Reuters $BIIB #Alzheimer's Disease… https://t.co/oMrWWPOCDQ January 27th 2023, 12:01am |
![]() |
@StckPro $BIIB NEW ARTICLE : Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Ac… https://t.co/KwLCPmFhrj January 26th 2023, 11:01pm |
![]() |
@ZacharyBrennan Europe wants in on lecanemab (Aduhelm was rejected there) $biib https://t.co/r85hcivrTp January 26th 2023, 11:01pm |
![]() |
@StckPro $BIIB NEW ARTICLE : Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Ac… https://t.co/QXu4uPOsAt January 26th 2023, 11:01pm |
![]() |
@semodough Goldberg - correct also as uptake of $BIIB Leqembi for Alzheimer’s Disease will likely ramp up in ‘24/’25” Bodes ve… https://t.co/ilGvZ0AMWi January 26th 2023, 11:01pm |
![]() |
@Beeken_health $BIIB - Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Accepted by Eu… https://t.co/1YXj4jUV9S January 26th 2023, 11:01pm |
![]() |
@algobotnews Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer's disease $BIIB $ESALY January 26th 2023, 11:01pm |
![]() |
@stonkmooncom $BIIB 2023-01-26 18:30 ET MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER'S D… https://t.co/eRByQPBMah January 26th 2023, 11:01pm |
![]() |
@StockNewsBot2 $BIIB Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by Euro… https://t.co/CcN0VxfwGa January 26th 2023, 11:01pm |
![]() |
@stock_titan $BIIB Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by Euro… https://t.co/JR3cSxooxU January 26th 2023, 11:01pm |
![]() |
@UsMarketNews $BIIB news Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Accepte… https://t.co/Zb54OET7Hr January 26th 2023, 11:01pm |
![]() |
@bthefirsttoknow First out// $BIIB: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Acc… https://t.co/PMfEgQHIQC January 26th 2023, 11:01pm |
![]() |
@Slayer10Stock $BIIB Open Interest => 69% (Puts) - 31% (Calls) @ 2023-01-27. Learn more at https://t.co/54bj3mKa5j. #BIIBSTOCK… https://t.co/RmjZqcDtUA January 26th 2023, 10:01pm |
![]() |
@V1stocks @MichaelWalstedt @markminervini I also looked closely at $BIIB I also carefully looked at BIIB, yesterday I bought a little? January 26th 2023, 9:01pm |
![]() |
@MichaelWalstedt $BIIB textbook @markminervini VCP setup here Super tight price action with the largest decline coming in at only -… https://t.co/PL7oJg5xFo January 26th 2023, 9:01pm |
![]() |
@Trade_Variance ? LARGE CALL SWEEP ORDER ? STOCK: $BIIB STRIKE: 300 EXPIRY: 7/21/2023 PREMIUM: $269,000 January 26th 2023, 5:01pm |
![]() |
@TLandstreet Amyloid plaque might just be a symptom. A majority of older people develop it yet few develop dimencia. $BIIB might… https://t.co/PxT3vtAnOX January 26th 2023, 5:01pm |
![]() |
@TLandstreet Want to know about amyloid plaque and why Biogen has to force approval of lecanemab? Listen to this: $BIIB https://t.co/MWxuCwuRoa January 26th 2023, 5:01pm |
![]() |
@LilaDea34313666 $BIIB Top analyst price target for next week- https://t.co/OPwNHr9bn7 January 26th 2023, 4:01pm |
![]() |
@TLandstreet Skepticism of $BIIB alzheimer's drug is growing. #lecanemab #leqembi https://t.co/C9SPL1u6EE January 26th 2023, 1:01pm |
![]() |
@StckPro $BIIB NEW ARTICLE : Is Biogen Stock a Buy Now? https://t.co/GHKkwLxj4F Get all the latest $BIIB related news here :… https://t.co/oUE2VWPhEg January 26th 2023, 12:01pm |
![]() |
@newsfilterio Massachusetts Virus Outbreak Looks Like Italy’s Just Two Weeks Ago $VRTX $BIIB https://t.co/iti1IoGT7O January 26th 2023, 9:01am |
![]() |
@Slayer10Stock $BIIB Open Interest => 69% (Puts) - 31% (Calls) @ 2023-01-27. Learn more at https://t.co/54bj3mKa5j. #BIIBSTOCK… https://t.co/Fw8oxtNVNA January 25th 2023, 11:01pm |
![]() |
@salomons_ed $BIIB Top analyst price target for next week>>> ?https://t.co/7vzzfiLE5g January 25th 2023, 7:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.